pembrolizumab
merck
['kn189']
impressive updated results for #kn189 trial by at #esmo22, looking at the tail of the curve: 5y os 19% 5y pfs 7.5% among pts that completed 35 cycles 40.4% alive without pd at 64mo mfup 3yos after 35 cycles: 71.9% 
MD, PhD - Asst Prof, Thoracic Oncology & Precision Medicine Unit Coordinator (CEMIC) ????. Implementing precision medicine programs in LATAM with PxMedica